MAPT and breast carcinoma: We used multivariate assays for the identification of 7 lncRNAs associated with necroptosis ultimately (AC010834.3, AL031186.1, AL136531.1, LINC01871, MAPT-AS1, SEMA3B-AS1, and AL606834.2) and applied them to develop a predictive prognostic risk signature of breast cancer.